15.306 articles found

Potential Disease-Modifying Effects of Ganglioside GM1 Pulse Treatment on Spinocerebellar Ataxia Type 3, a Parallel-Group, Double-Blind, Randomized, Controlled Trial.

Chen YK, Tian HY, Zhu QY, Zhang R, Liang DX, Wang JQ, Feng RY, Qin C, Ma MM, Jiang H, Tang BS, Ding XB, Wang XJ.

Mov Disord · 2024-11-07

DOI: 10.1002/mds.30050PMID: 39508583

Clinical and cognitive features associated with psychosis in Parkinson's disease: a longitudinal study.

Flanigan JL, Harrison MB, Patrie JT, Shah BB, Sperling SA, Wyman-Chick KA, Dalrymple WA, Barrett MJ.

Front Aging Neurosci · 2024-11-06

DOI: 10.3389/fnagi.2024.1463426PMID: 39574488

Investigating the relationship between cognitive disorders and fatigue in patients with Parkinson's and its relationship with individual and clinical factors in Isfahan city

Maghzi P, Nazari F, Chitsaz A, Kouhi N.

· 2024-11-05

DOI: 10.21203/rs.3.rs-5191324/v1

Clinical characteristics of PD patients carrying LRRK2 R1628P variant

Deng X, Kuruvilla J, Ng EY, Lo Y, Xu Z, Tay K, Au W, Tan LC, Tan E, Xiao B.

· 2024-11-05

DOI: 10.21203/rs.3.rs-5321847/v1

Understanding Parkinson disease in Spain: Genetic and clinical insights.

Gómez-Garre P, Martín-Bórnez M, Muñoz-Delgado L, Díaz-Belloso R, Periñán MT, Bonilla-Toribio M, Buiza-Rueda D, Macías-García D, Jesús S, Adarmes-Gómez A, Ojeda E, Luque-Ambrosiani A, García-Díaz S, Sánchez RP, Carrillo F, Mir P.

Eur J Neurol · 2024-11-05

DOI: 10.1111/ene.16499PMID: 39498811

Causal Mediation Analysis of Factors Influencing Physical Activity and Community Access Among People With Mild-to-Moderate Parkinson Disease.

Paul SS, Porciuncula F, Cavanaugh JT, Rawson KS, Nordahl TJ, Baker TC, Duncan RP, Earhart GM, Ellis TD.

Arch Phys Med Rehabil · 2024-11-05

DOI: 10.1016/j.apmr.2024.10.012PMID: 39505247

Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases.

Costa T, Manuello J, Premi E, Mattioli I, Lasagna L, Lahoz CB, Cauda F, Duca S, Liloia D.

Sci Rep · 2024-11-02

DOI: 10.1038/s41598-024-78132-9PMID: 39487289

Cerebellar Transcranial Direct Current Stimulation in the Cerebellar Cognitive Affective Syndrome: A Randomized, Double-Blind, Sham-Controlled Trial.

Reumers SFI, Maas RPPWM, Schutter DJLG, Teerenstra S, Kessels RPC, de Leeuw FE, van de Warrenburg BPC.

Mov Disord · 2024-11-02

DOI: 10.1002/mds.30043PMID: 39487643

Clinical progression of Parkinson's disease in the early 21st century: Insights from the accelerating medicine partnership (AMP-PD) data.

Lewis MM, Mailman RB, Cheng XV, Du G, Zhang L, Li C, De Jesus S, Tabbal SD, Li R, Huang X.

Parkinsonism Relat Disord · 2024-11-02

DOI: 10.1016/j.parkreldis.2024.107186PMID: 39541725

Retrospective analysis of diet and gut microbiota diversity and clinical pharmacology outcomes in patients with Parkinsonism syndrome

Hu Y, Wang H, Zhong Y, Sun Y.

Heliyon · 2024-11-01

Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.

Wei Y, Li H, Li Y, Zeng Y, Quan T, Leng Y, Chang E, Bai Y, Bian Y, Hou Y.

Front Pharmacol · 2024-11-01

DOI: 10.3389/fphar.2024.1496661PMID: 39555102

Motor compensation in Parkinson's disease: an empirical challenge with clinical implications.

Ballanger B, Boulinguez P.

Brain · 2024-11-01

DOI: 10.1093/brain/awae328PMID: 39414256